KR20140106703A - 술포닐아미노피롤리디논 유도체, 그의 제조법 및 그의 치료 용도 - Google Patents

술포닐아미노피롤리디논 유도체, 그의 제조법 및 그의 치료 용도 Download PDF

Info

Publication number
KR20140106703A
KR20140106703A KR1020147019821A KR20147019821A KR20140106703A KR 20140106703 A KR20140106703 A KR 20140106703A KR 1020147019821 A KR1020147019821 A KR 1020147019821A KR 20147019821 A KR20147019821 A KR 20147019821A KR 20140106703 A KR20140106703 A KR 20140106703A
Authority
KR
South Korea
Prior art keywords
pyrrolidin
oxo
propionic acid
sulfonylamino
thiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147019821A
Other languages
English (en)
Korean (ko)
Inventor
나탈리에 알레
장-미쉘 알텐부르게
장-파스칼 허로울트
라인하르트 키르슈
질베르 라자이으
제르지오 말라르
마리-끌레르 필리포-오르츠
Original Assignee
사노피
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피 filed Critical 사노피
Publication of KR20140106703A publication Critical patent/KR20140106703A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1020147019821A 2011-12-21 2012-12-19 술포닐아미노피롤리디논 유도체, 그의 제조법 및 그의 치료 용도 Ceased KR20140106703A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11306733.4 2011-12-21
EP11306733.4A EP2606893A1 (en) 2011-12-21 2011-12-21 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
PCT/EP2012/076224 WO2013092756A1 (en) 2011-12-21 2012-12-19 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application

Publications (1)

Publication Number Publication Date
KR20140106703A true KR20140106703A (ko) 2014-09-03

Family

ID=47428640

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147019821A Ceased KR20140106703A (ko) 2011-12-21 2012-12-19 술포닐아미노피롤리디논 유도체, 그의 제조법 및 그의 치료 용도

Country Status (18)

Country Link
US (1) US9150544B2 (https=)
EP (2) EP2606893A1 (https=)
JP (1) JP6104936B2 (https=)
KR (1) KR20140106703A (https=)
CN (1) CN104136030B (https=)
AR (1) AR089397A1 (https=)
AU (1) AU2012357123B2 (https=)
BR (1) BR112014014869A2 (https=)
CA (1) CA2859575A1 (https=)
ES (1) ES2559854T3 (https=)
IL (1) IL233238A (https=)
IN (1) IN2014CN04861A (https=)
MX (1) MX347620B (https=)
RU (1) RU2014129787A (https=)
SG (1) SG11201403336QA (https=)
TW (1) TWI568727B (https=)
UY (1) UY34543A (https=)
WO (1) WO2013092756A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1307759B1 (it) 1998-03-31 2001-11-19 Schurr Stahlecker & Grill Dispositivo per condensare un composito di fibre stirato.
DE19838762B4 (de) 1998-08-26 2009-04-16 Maschinenfabrik Rieter Ag Spinnmaschine mit einer Vielzahl von Spinnstellen
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
CN104557928B (zh) * 2015-02-14 2016-08-24 佛山市赛维斯医药科技有限公司 一种含二环酰胺结构凝血因子Xa抑制剂、其制备方法及其用途
CN112969698A (zh) * 2018-11-08 2021-06-15 葛兰素史密斯克莱知识产权发展有限公司 化学化合物
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide
CN113264819B (zh) * 2021-05-25 2024-11-05 都创(上海)医药开发有限公司 一种基于连续流反应技术快速合成3-溴-2-氟苯甲醛的方法
TW202404583A (zh) 2022-06-08 2024-02-01 加拿大商再諾製藥公司 吡啶胺衍生物及其作為鉀通道調節劑之用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4121947A1 (de) * 1991-07-03 1993-01-07 Basf Ag 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung
US6602864B1 (en) 1996-12-13 2003-08-05 Aventis Pharma Deutschland Gmbh Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
IL130152A0 (en) * 1996-12-13 2000-06-01 Rhone Poulenc Rorer Pharma Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclyamide compounds
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Medicinal compounds

Also Published As

Publication number Publication date
AR089397A1 (es) 2014-08-20
TW201331195A (zh) 2013-08-01
CN104136030B (zh) 2017-03-01
EP2793887A1 (en) 2014-10-29
MX2014007671A (es) 2014-11-25
AU2012357123B2 (en) 2016-12-15
JP2015502382A (ja) 2015-01-22
MX347620B (es) 2017-05-04
WO2013092756A1 (en) 2013-06-27
AU2012357123A1 (en) 2014-07-10
IL233238A0 (en) 2014-08-31
IN2014CN04861A (https=) 2015-09-18
US9150544B2 (en) 2015-10-06
EP2606893A1 (en) 2013-06-26
TWI568727B (zh) 2017-02-01
JP6104936B2 (ja) 2017-03-29
IL233238A (en) 2016-10-31
EP2793887B1 (en) 2015-10-21
SG11201403336QA (en) 2014-07-30
BR112014014869A2 (pt) 2017-06-13
RU2014129787A (ru) 2016-02-10
UY34543A (es) 2013-06-28
ES2559854T3 (es) 2016-02-16
CA2859575A1 (en) 2013-06-27
CN104136030A (zh) 2014-11-05
US20140329801A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
JP6104936B2 (ja) スルホニルアミノピロリジノン誘導体、その製造およびその治療適用
KR102090780B1 (ko) 혈전색전성 질환의 치료를 위한 인자 xia 억제제로서 치환된 피롤리딘
US5750520A (en) Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives
TWI633091B (zh) 作為因子xia抑制劑之經取代四氫異喹啉化合物
JP2020203939A (ja) 治療用化合物および組成物
US5798352A (en) Antithrombotic amidinotetrahydropyridylalanine derivatives
JP2001502674A (ja) 選択的Xa因子阻害物質
CN117916236A (zh) 取代的s-丙氨酸酯衍生物
HUT74871A (en) Nipecotic acid derivatives as antithrombic compounds
JPH11507366A (ja) トロンビン阻害剤類
JP2005533064A (ja) 2,5−ジ置換3−メルカプトペンタン酸
AU2005225523A1 (en) Novel pyrrolidine-3,4-dicarboxamide derivatives
JP4446145B2 (ja) ベンズアミジン誘導体
JPWO2001042254A1 (ja) ベンズアミジン誘導体
JP2008535887A (ja) 第Xa因子阻害剤としての3−スルホニルアミノ−ピロリジン−2−オン誘導体
CN116745278A (zh) 酶抑制剂
JP2006527728A (ja) Xa因子の阻害剤としての2−ピロリドン誘導体およびその使用
HK1207854B (en) Substituted pyrrolidines as factor xia inhibitors for the treatment of thromboembolic diseases

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140716

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20171117

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190117

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190320

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20190117

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I